The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
ASAP CRN 2025 RFA Scientific Track, 2026Connecting the Environmental Exposome to PD Risk and Disease Pathology
Study Rationale:
We now know that many cases of Parkinson’s disease are caused by exposure to harmful chemicals and pesticides in the environment. However, it is paradoxical...
-
ASAP CRN 2025 RFA Scientific Track, 2026Investigating the Role of Immune Cell Exhaustion (ICE) and Biological Immune Aging (BIA) in PD Risk and PD Heterogeneity
Study Rationale:
Parkinson’s disease (PD) affects people in very different ways. This project will study the biological reasons that may explain this variability. In particular, it will focus on how...
-
ASAP CRN 2025 RFA Scientific Track, 2026Decoding Alpha-Synuclein Conformational Diversity to Enable Advanced Predictive Amplification Assays
Study Rationale:
Our Team’s research shows that special forms of α-synuclein protein extracted or amplified from biospecimen donations from people with Parkinson’s disease...
-
ASAP CRN 2025 RFA Scientific Track, 2026Defining the Neural Mechanisms Underlying Heterogeneity in Sleep and Circadian Rhythm Disturbances in Parkinson’s Disease
Study Rationale:
People affected by Parkinson’s experience a range of sleep problems such as excessive daytime sleeping and difficulty sleeping at night. These issues can make...
-
ASAP CRN 2025 RFA Scientific Track, 2026Seeded Aggregation of Alpha-Synuclein
Study Rationale:
Filamentous aggregates of the protein alpha-synuclein underlie several neurodegenerative diseases, called synucleinopathies. Parkinson’s disease (PD) is the most common...
-
ASAP CRN 2025 RFA Scientific Track, 2026Aging and the Heterogeneity of Parkison’s Disease – The Role of Heterochromatin Erosion
Study Rationale:
Age is the single most significant risk factor for developing Parkinson’s disease (PD), but the mechanisms by which aging contributes to PD are not well...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.